Strategies to prevent kidney injury from antibiotics in people with cystic fibrosis

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of strategies (such as altering the type and dose of intravenous antibiotics, the avoidance of other nephrotoxic drugs alongside the intravenous antibiotics and the use of adjuvant medication including statins and fluids) to reduce or prevent kidney damage in people with CF which occurs as a results of intravenous antibiotic treatment.